NFSG
COYA icon

Newbridge Financial Services Group’s Coya Therapeutics COYA Stock Holding History

Newbridge Financial Services Group’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-70,000
Closed -$401K – 1063
2024
Q4 		$401K Buy
+70,000
New +$477K 0.1% 134

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Newbridge Financial Services Group's COYA Position: Q1 2025 in Review

Newbridge Financial Services Group sold out of Coya Therapeutics (COYA) in Q1 2025, closing a stake of 70,000 shares — an estimated $401K sold.

Newbridge Financial Services Group first reported a position in COYA in Q4 2024 and held it in 1 quarter. The position peaked at $401K in Q4 2024. 26 funds tracked by Wall St. Rank hold COYA as of Q1 2025.

  • Newbridge Financial Services Group reported no remaining Coya Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Newbridge Financial Services Group sold 70,000 Coya Therapeutics shares in Q1 2025, an estimated $401K.
  • Newbridge Financial Services Group first reported a position in Coya Therapeutics in Q4 2024 and held it in 1 quarter.
  • Newbridge Financial Services Group's Coya Therapeutics position peaked at $401K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2025.

Based on Newbridge Financial Services Group's 13F filing for Q1 2025, filed 15 May 2025.